of amyotrophic lateral sclerosis

By John D. Lee, N. A. Kamaruzaman, J. Fung, Stephen M. Taylor, Bradley J. Turner, J. Atkin, Trent M. Woodruff, P. G. Noakes. 2013

1,557 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/0f16035f23d113f7eada725207713e26ff59e234

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Brian J. Wainger
2. S. Allen
3. A. Prasad
4. Cassidy Mellin
5. Judy J. Watson
6. E. Kiskinis
7. D. Shoemark
8. Ole Wiskow

Citations in the corpus

• GDNF, NGF and BDNF as therapeutic options for neurodegeneration. (2013, background): “ALS (also called Lou Gehrig's disease) is a disease primarily involving the death of the motor neurones in the spinal cord, brain stem and motor cortex (Kiernan et al., 2011).”
• Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis (2019, background): “ALS is a fatal neurodegenerative disease characterized by progressive degeneration of both the upper and lower motor neurons, which display cytoplasmic inclusions (Rowland and Shneider, 2001; Kiernan et al., 2011).”
• Intrinsic Membrane Hyperexcitability of ALS Patient-Derived Motor Neurons (2014, background): “Amyotrophic lateral sclerosis (ALS) is a devastating, untreatable disease of upper and lower motor neurons (Kiernan et al., 2011).”